Intra-Cellular Therapies Inc
F:23I
Intra-Cellular Therapies Inc
F:23I
Price:
122
EUR
0.83%
Market Closed
Market Cap:
€12.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Intra-Cellular Therapies Inc
F:23I
|
US |
|
G
|
Great Eagle Holdings Ltd
F:GHK
|
HK |
|
Lee's Pharmaceutical Holdings Ltd
F:L1PA
|
HK |
|
A
|
Alter Ego Media SA
ATHEX:AEM
|
GR |
|
K
|
Knight Club Capital Asset Management PCL
SET:KCC
|
TH |
|
E
|
ERWE Immobilien AG
F:ERWE
|
DE |
|
D
|
DYD Co Ltd
KOSDAQ:219550
|
KR |
|
D
|
Divide Drives Inc
OTC:DVDR
|
US |
|
Starcrest Education The Belt & Road Ltd
LSE:OBOR
|
CN |
|
SRM Energy Ltd
BSE:523222
|
IN |
|
B
|
Borders and Southern Petroleum PLC
F:B5T
|
UK |
|
AJA Health And Wellness Inc
XTSX:AJA
|
CA |
|
Prostatype Genomics AB
OTC:PGABF
|
SE |
|
Hemostemix Inc
F:2VF0
|
CA |
|
I
|
Instant Group AG
SWB:CCB
|
DE |
|
Emerald Plantation Holdings Ltd
OTC:EMEXF
|
HK |
|
N
|
New Media Capital 20 Inc
XTSX:ATOI
|
CA |
|
A
|
Advanced Connection Corporation PCL
SET:ACC
|
TH |
|
Roscan Gold Corp
XTSX:ROS
|
CA |
|
PowerBank Corp
NASDAQ:PBK
|
CA |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 23I's stock price target?
Not Available
23I does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Intra-Cellular Therapies Inc?
Projected CAGR
48%
48%
Over the last 12 years, the compound annual growth rate for Revenue has been 57%. The projected CAGR for the next 3 years is 48%.
